Pillar Technology Group

Pillar Biosciences is a clinical cancer diagnostics company that develops next-generation sequencing (NGS) solutions to simplify and accelerate precision medicine. The company's proprietary SLIMamp (Stem-Loop Inhibition-Mediated amplification) technology enables highly sensitive and specific enrichment of target sequences, facilitating decentralized NGS testing. Their flagship oncoReveal products, including FDA-approved companion diagnostics, provide clinicians with actionable genomic data to guide personalized therapy for various cancers. By streamlining the diagnostic workflow and reducing turnaround times, Pillar Biosciences aims to make high-quality genomic insights accessible to patients globally.